A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003) (NCT07619443) | Clinical Trial Compass
Not Yet RecruitingPhase 1
A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)
30 participantsStarted 2026-07-06
Plain-language summary
The goal of this study is to learn what happens to a single dose of enlicitide over time in a healthy participant's body when the participant is given a single dose of MK-7262 and what happens to a single dose of MK-7262 over time in a healthy participant's body when the participant is given a single dose of enlicitide.
Who can participate
Age range
19 Years – 55 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
The main inclusion criteria include but are not limited to the following:
* Is in good health before randomization
* Has a body mass index (BMI) ≥18 and ≤32 kg/m\^2, inclusive
Exclusion Criteria:
The main exclusion criteria include but are not limited to the following:
* Has a history or presence of clinically significant medical or psychiatric condition or disease
* Has a history of cancer
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Area Under the Concentration-Time Curve From Time 0 to Infinity (AUC0-inf) of MK-7262
Timeframe: Predose and at designated time points post-dose (up to 8 days)
2
AUC0-inf of Enlicitide
Timeframe: Predose and at designated time points post-dose (up to 8 days post-dose)
3
Maximum Plasma Concentration (Cmax) of MK-7262
Timeframe: Predose and at designated time points post-dose (up to 8 days post-dose)
4
Cmax of Enlicitide
Timeframe: Predose and at designated time points post-dose (up to 8 days post-dose)